459 related articles for article (PubMed ID: 29317486)
1. Mutual dependence of the MRTF-SRF and YAP-TEAD pathways in cancer-associated fibroblasts is indirect and mediated by cytoskeletal dynamics.
Foster CT; Gualdrini F; Treisman R
Genes Dev; 2017 Dec; 31(23-24):2361-2375. PubMed ID: 29317486
[TBL] [Abstract][Full Text] [Related]
2. Mechanosensitive transcriptional coactivators MRTF-A and YAP/TAZ regulate nucleus pulposus cell phenotype through cell shape.
Fearing BV; Jing L; Barcellona MN; Witte SE; Buchowski JM; Zebala LP; Kelly MP; Luhmann S; Gupta MC; Pathak A; Setton LA
FASEB J; 2019 Dec; 33(12):14022-14035. PubMed ID: 31638828
[TBL] [Abstract][Full Text] [Related]
3. Myocardin-Related Transcription Factor A and Yes-Associated Protein Exert Dual Control in G Protein-Coupled Receptor- and RhoA-Mediated Transcriptional Regulation and Cell Proliferation.
Yu OM; Miyamoto S; Brown JH
Mol Cell Biol; 2016 Jan; 36(1):39-49. PubMed ID: 26459764
[TBL] [Abstract][Full Text] [Related]
4. TGF-β1 regulates the expression and transcriptional activity of TAZ protein via a Smad3-independent, myocardin-related transcription factor-mediated mechanism.
Miranda MZ; Bialik JF; Speight P; Dan Q; Yeung T; Szászi K; Pedersen SF; Kapus A
J Biol Chem; 2017 Sep; 292(36):14902-14920. PubMed ID: 28739802
[TBL] [Abstract][Full Text] [Related]
5. MRTF potentiates TEAD-YAP transcriptional activity causing metastasis.
Kim T; Hwang D; Lee D; Kim JH; Kim SY; Lim DS
EMBO J; 2017 Feb; 36(4):520-535. PubMed ID: 28028053
[TBL] [Abstract][Full Text] [Related]
6. Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer.
Jung O; Baek MJ; Wooldrik C; Johnson KR; Fisher KW; Lou J; Ricks TJ; Wen T; Best MD; Cryns VL; Anderson RA; Choi S
EMBO J; 2024 May; 43(9):1740-1769. PubMed ID: 38565949
[TBL] [Abstract][Full Text] [Related]
7. YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity.
Yu OM; Benitez JA; Plouffe SW; Ryback D; Klein A; Smith J; Greenbaum J; Delatte B; Rao A; Guan KL; Furnari FB; Chaim OM; Miyamoto S; Brown JH
Oncogene; 2018 Oct; 37(41):5492-5507. PubMed ID: 29887596
[TBL] [Abstract][Full Text] [Related]
8. TEAD mediates YAP-dependent gene induction and growth control.
Zhao B; Ye X; Yu J; Li L; Li W; Li S; Yu J; Lin JD; Wang CY; Chinnaiyan AM; Lai ZC; Guan KL
Genes Dev; 2008 Jul; 22(14):1962-71. PubMed ID: 18579750
[TBL] [Abstract][Full Text] [Related]
9. Nuclear actin regulates cell proliferation and migration via inhibition of SRF and TEAD.
McNeill MC; Wray J; Sala-Newby GB; Hindmarch CCT; Smith SA; Ebrahimighaei R; Newby AC; Bond M
Biochim Biophys Acta Mol Cell Res; 2020 Jul; 1867(7):118691. PubMed ID: 32119877
[TBL] [Abstract][Full Text] [Related]
10. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.
Edwards DN; Ngwa VM; Wang S; Shiuan E; Brantley-Sieders DM; Kim LC; Reynolds AB; Chen J
Sci Signal; 2017 Dec; 10(508):. PubMed ID: 29208682
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
[TBL] [Abstract][Full Text] [Related]
12. YAP/TAZ enhance mammalian embryonic neural stem cell characteristics in a Tead-dependent manner.
Han D; Byun SH; Park S; Kim J; Kim I; Ha S; Kwon M; Yoon K
Biochem Biophys Res Commun; 2015 Feb; 458(1):110-6. PubMed ID: 25634692
[TBL] [Abstract][Full Text] [Related]
13. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3.
Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC
Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596
[TBL] [Abstract][Full Text] [Related]
14. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain.
Lamar JM; Stern P; Liu H; Schindler JW; Jiang ZG; Hynes RO
Proc Natl Acad Sci U S A; 2012 Sep; 109(37):E2441-50. PubMed ID: 22891335
[TBL] [Abstract][Full Text] [Related]
15. Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition.
Diepenbruck M; Waldmeier L; Ivanek R; Berninger P; Arnold P; van Nimwegen E; Christofori G
J Cell Sci; 2014 Apr; 127(Pt 7):1523-36. PubMed ID: 24554433
[TBL] [Abstract][Full Text] [Related]
16. Serum Inter-α-inhibitor activates the Yes tyrosine kinase and YAP/TEAD transcriptional complex in mouse embryonic stem cells.
Pijuan-Galitó S; Tamm C; Annerén C
J Biol Chem; 2014 Nov; 289(48):33492-502. PubMed ID: 25301940
[TBL] [Abstract][Full Text] [Related]
17. MRTF/SRF dependent transcriptional regulation of TAZ in breast cancer cells.
Liu CY; Chan SW; Guo F; Toloczko A; Cui L; Hong W
Oncotarget; 2016 Mar; 7(12):13706-16. PubMed ID: 26885614
[TBL] [Abstract][Full Text] [Related]
18. YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation.
He L; Pratt H; Gao M; Wei F; Weng Z; Struhl K
Elife; 2021 Aug; 10():. PubMed ID: 34463254
[TBL] [Abstract][Full Text] [Related]
19. Allosteric Modulation of the YAP/TAZ-TEAD Interaction by Palmitoylation and Small-Molecule Inhibitors.
Mills KR; Misra J; Torabifard H
J Phys Chem B; 2024 Apr; 128(16):3795-3806. PubMed ID: 38606592
[TBL] [Abstract][Full Text] [Related]
20. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]